Your browser doesn't support javascript.
loading
Assessing the efficacy of targeting the phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway in endometrial cancer.
Bradford, Leslie S; Rauh-Hain, Alejandro; Clark, Rachel M; Groeneweg, Jolijn W; Zhang, Ling; Borger, Darrell; Zukerberg, Lawrence R; Growdon, Whitfield B; Foster, Rosemary; Rueda, Bo R.
Afiliação
  • Bradford LS; Vincent Center for Reproductive Biology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA; Gynecologic Oncology Division, Vincent Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical Sc
  • Rauh-Hain A; Vincent Center for Reproductive Biology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA; Gynecologic Oncology Division, Vincent Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical Sc
  • Clark RM; Vincent Center for Reproductive Biology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA; Gynecologic Oncology Division, Vincent Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical Sc
  • Groeneweg JW; Vincent Center for Reproductive Biology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA.
  • Zhang L; Vincent Center for Reproductive Biology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Borger D; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA 02115, USA.
  • Zukerberg LR; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA.
  • Growdon WB; Vincent Center for Reproductive Biology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA; Gynecologic Oncology Division, Vincent Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical Sc
  • Foster R; Vincent Center for Reproductive Biology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA; Gynecologic Oncology Division, Vincent Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical Sc
  • Rueda BR; Vincent Center for Reproductive Biology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA; Gynecologic Oncology Division, Vincent Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical Sc
Gynecol Oncol ; 133(2): 346-52, 2014 May.
Article em En | MEDLINE | ID: mdl-24561032

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinossarcoma / Transdução de Sinais / Protocolos de Quimioterapia Combinada Antineoplásica / Morfolinas / Neoplasias do Endométrio / Carcinoma Endometrioide / Proteínas Proto-Oncogênicas c-akt / Serina-Treonina Quinases TOR / Inibidores de Fosfoinositídeo-3 Quinase / Aminopiridinas Limite: Animals / Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinossarcoma / Transdução de Sinais / Protocolos de Quimioterapia Combinada Antineoplásica / Morfolinas / Neoplasias do Endométrio / Carcinoma Endometrioide / Proteínas Proto-Oncogênicas c-akt / Serina-Treonina Quinases TOR / Inibidores de Fosfoinositídeo-3 Quinase / Aminopiridinas Limite: Animals / Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2014 Tipo de documento: Article